Apohem

Apohem is a Swedish e-commerce company specializing in health and beauty products, offering a range of pharmaceuticals, skincare, and nutritional supplements tailored to enhance wellness. Founded in 2017 in Stockholm, Sweden, Apohem focuses on direct-to-consumer health and beauty solutions. The company was established through a partnership involving NovAx and Axfood, among other investors, and is designed to meet the growing demand for online health products. The CEO is Gustav Hasselgren, with Henrik P as one of the founders.

Apohem has completed one investment deal as of June 1, 2017. Apohem specializes in a comprehensive range of health and beauty products, primarily focusing on pharmaceuticals, skincare, nutritional supplements, and personal care items. The company's core offerings include over-the-counter medications, vitamins, and various skincare brands such as La Roche-Posay and Dermalogica. These products are designed to address common health and beauty needs, including skincare for sensitive skin, allergy relief, and overall wellness through dietary supplements.

Apohem serves a diverse clientele, including individual consumers seeking personal care solutions as well as families in need of child-specific products. The company operates primarily in Sweden and markets its products through its online platform, ensuring convenience and direct access to its customer base. In the most recent fiscal year of 2024, Apohem reported a revenue of USD 84. 48 mn and an EBITDA of USD 8.

20 mn, indicating a solid financial performance driven by its e-commerce operations. Apohem plans to expand its product line by introducing new health and beauty items, which are currently under development. The company aims to penetrate additional Scandinavian markets by mid-2025. Recent funding from its 2017 investment will be directed towards enhancing its product offerings and bolstering market presence, enabling a more competitive stance in the e-commerce landscape.